I respectfully disagree. The NYT paid the author, Gina Kolata, to research and write the story, which contains more details than just the press release alone, then used their platform to made the news widely available and thus helped people like me discover it.
As cynical as one may be about the state of contemporary journalism, I'd say that short articles like this are still something good that comes out of newspapers in 2025, and I hope it doesn't go away just yet.
(2024) "Pharmacology and Mechanism of Action
of Suzetrigine, a Potent and Selective NaV1.8 Pain
Signal Inhibitor for the Treatment of Moderate
to Severe Pain" (pdf)
There is at least one: in its quest to promote the agency they forgot to list the most basic issue that makes this approval noteworthy - addiction. Also there is no price and a bunch of other relevant info
There is a lot more information and background for the layperson in the NYT article. But free sources should also be included for those without a subscription.
>>suzetrigine helped those with diabetic neuropathy, but was no better than placebo in those with pinched spinal nerves.
(…) While analysts and researchers deemed the results disappointing in patients with pinched nerves in their spines, the company decided to proceed because there are no approved drugs for the painful condition, and because the drug is safe and “the mechanism of action is so clearly validated.”
“No one has ever helped these four million people,” he said. <<
Aside from routinely burning the nerves, routine epidural injections, narcotics, or alcohol.
Extremely limited relief from expensive acupuncture, massage, TENS, stretching, etc.
How does one give someone a placebo after surgery for clinical trials ? Wouldn’t that cause a lot of pain ? I know science and research and trials and all etc etc, but pain post surgery is quite a lot that placebo alone would be really bad for the patient.
Super exciting development in the world of medicine, but the price tag is really steep. Starting at US$15.50 per pill, and you're supposed to take two pills at a time. Many will opt for cheaper options.
Disclaimer: I'm Canadian with extended insurance, so I have little perspective on drug prices.
This is to treat acute pain, probably mostly post-op as alternative to opioids. At most you'll probably get a week's worth of pills from your doc post-op, and I would say the cost is worth it if it works better than NSAIDs and it's not addictive.
BugsJustFindMe|1 year ago
https://www.fda.gov/news-events/press-announcements/fda-appr...
dewitt|1 year ago
I respectfully disagree. The NYT paid the author, Gina Kolata, to research and write the story, which contains more details than just the press release alone, then used their platform to made the news widely available and thus helped people like me discover it.
As cynical as one may be about the state of contemporary journalism, I'd say that short articles like this are still something good that comes out of newspapers in 2025, and I hope it doesn't go away just yet.
photochemsyn|1 year ago
https://link.springer.com/content/pdf/10.1007/s40122-024-006...
eviks|1 year ago
unethical_ban|1 year ago
el_duderino|1 year ago
instagib|1 year ago
“No one has ever helped these four million people,” he said. <<
Aside from routinely burning the nerves, routine epidural injections, narcotics, or alcohol.
Extremely limited relief from expensive acupuncture, massage, TENS, stretching, etc.
bustling-noose|1 year ago
jjeaff|1 year ago
oliwarner|1 year ago
luafox|1 year ago
Disclaimer: I'm Canadian with extended insurance, so I have little perspective on drug prices.
ArlenBales|1 year ago
unethical_ban|1 year ago
bookofjoe|1 year ago
montroser|1 year ago
loloquwowndueo|1 year ago
rufus_foreman|1 year ago
From my brief experience with junkies, they will treat this as a challenge.